Usana Health Sciences (USNA) Cash from Financing Activities (2011 - 2026)

Usana Health Sciences (USNA) has 16 years of Cash from Financing Activities data on file, last reported at -$3.6 million in Q2 2026.

• Cash from Financing Activities for Q2 2026 came in at -$3.6 million, up 74.83% year-over-year; the trailing twelve-month figure through Apr 2026 was -$29.8 million (down 523.45% YoY), and the FY2026 annual result was -$40.6 million, down 525.03% from the prior year.
• Cash from Financing Activities retreated to -$3.6 million in Q2 2026 per USNA's latest filing, from $13.5 million in the prior quarter.
• Over five years, Cash from Financing Activities peaked at $22.9 million in Q4 2024 and troughed at -$122.4 million in Q1 2022.
• A 5-year average of -$11.2 million and a median of -$2.3 million in 2023 frame the typical range for Cash from Financing Activities.
• The sharpest annual moves came in 2023 and 2024: Cash from Financing Activities tumbled 26356.82% in 2023, then jumped 3384.8% in 2024.
• A 5-year view of Cash from Financing Activities shows it stood at -$150000.0 in 2022, then soared by 538.67% to $658000.0 in 2023, then jumped by 3384.8% to $22.9 million in 2024, then sank by 104.27% to -$979000.0 in 2025, then slumped by 271.91% to -$3.6 million in 2026.
• Business Quant data shows USNA's Cash from Financing Activities at -$3.6 million in Q2 2026, $13.5 million in Q1 2026, and -$979000.0 in Q3 2025.